Coave Therapeutics
A clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€142—212m (Dealroom.co estimates Jul 2021.)
Company register number 800830721
Paris Île-de-France (HQ)
Authorizing premium user...